Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PCI 45227 is an active metabolite of the Bruton's tyrosine kinase inhibitor ibrutinib .1PCI 45227 is formed from ibrutinib by the cytochrome P450 (CYP) isoform CYP3A.
Description | PCI 45227 is an active metabolite of the Bruton's tyrosine kinase inhibitor ibrutinib .1PCI 45227 is formed from ibrutinib by the cytochrome P450 (CYP) isoform CYP3A. |
Molecular Weight | 474.521 |
Formula | C25H26N6O4 |
CAS No. | 1654820-87-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methanol: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydrodiol-Ibrutinib 1654820-87-7 Dihydrodiol Ibrutinib DihydrodiolIbrutinib inhibitor inhibit